In regional healthcare referral networks, specialty care is provided at a few sites within the network, with patients referred there for management. This model may increase access to specialized care but also increases the distance that patients travel to receive such care, with unknown effects on longitudinal outcomes. The Veterans Administration uses such regional models for percutaneous coronary intervention (PCI). The impact of patient distance from specialty centers on longitudinal outcomes after receipt of specialized care is understudied and may carry implications for care delivery models.
R
egional referral networks centralize specialty medical care, often using a spoke and hub model where smaller spoke facilities refer complex or specialized care to larger, central hub facilities. Such networks were developed with the intent of concentrating experience for complex or specialized medical care, in response to data supporting a volume-outcome relationship across several diagnoses and procedures. [1] [2] [3] [4] [5] [6] However, this centralization may have unintended effects on access to care, with patients required to travel longer distances to receive specialty care or procedures. 7 Although prior studies have demonstrated that distance traveled can impact access to care and inhospital outcomes, [8] [9] [10] [11] few studies have addressed outcomes after hospital discharge for patients needing to travel long distances, once they return to their local spoke facilities. The impact of distance from specialty care in these regional referral networks on longitudinal patient outcomes remains understudied.
Regional referral models of care are often used for cardiovascular care. Percutaneous coronary intervention (PCI) is a complex and highly specialized procedure used to treat coronary artery disease. Evaluations of PCI have demonstrated a consistent association between annual volume and patient outcomes, [12] [13] [14] and national cardiovascular societal guidelines recommend performance of a minimum number of PCIs annually to ensure ongoing proficiency. 15, 16 In response, some healthcare networks have centralized PCI to certain centers to maintain procedural volumes. However, this may lead to greater travel distances for patients requiring PCI, with unknown consequences for patient outcomes. Furthermore, care after PCI can be complex and often requires ongoing management that may not be readily available outside of these centralized centers when patients are discharged home. Given that coronary artery disease is a common, chronic disease requiring ongoing care and management after PCI, it is important to assess whether patient distance has an impact on longitudinal outcomes.
Accordingly, the objective of this study was to assess the association between patient travel distance from specialty PCI care and longitudinal risk of adverse events. The Veterans Health Administration (VHA) uses a regional referral spoke and hub model, with only 67 of its 149 medical centers able to perform PCI, requiring many veterans to travel long distances. With a cohort identified using the Veterans Affairs (VA) Clinical Assessment, Reporting, and Tracking program, we first defined the range of distances traveled by veterans undergoing PCI within the VHA. Second, we sought to assess the association between distance traveled and the risk of death or myocardial infarction (MI) in the year after PCI. If an association exists between distance and adverse events, it would highlight a need to identify factors mediating such a relationship and suggest an opportunity for establishing systems of care to improve longitudinal follow-up for veterans undergoing PCI.
METHODS
The data, analytic methods, and study materials will not be made available to other researchers for purposes of reproducing the results.
Data Sources
Data for this analysis were obtained from the Veterans Affairs Clinical Assessment, Reporting, and Tracking System Program, which is a national clinical quality program for all cardiac catheterization laboratories in the VHA. This program uses a software application embedded within the electronic health record to capture standardized patient and procedural data elements for all coronary procedures performed in any VA catheterization laboratory. 17 Participation in Clinical Assessment, Reporting, and Tracking is mandatory and universal in all VHA cardiac catheterization laboratories. Data elements are derived from the National Cardiovascular Data Registry data definitions, 18 with periodic quality assessments for completeness, accuracy, and validity. 19 Data were also obtained from the VA Corporate Data Warehouse, a repository of patient, pharmaceutical, and procedural characteristics, and the Master Patient Index.
Study Cohort
We identified all patients undergoing PCI within the VHA from 2008 to 2012, to assess care and outcomes following the initial contact with the PCI center. We excluded patients with private insurance indicated as their primary coverage and patients not using the VHA as their primary source of medical
WHAT IS KNOWN
• Prior analyses have demonstrated an association between the distance from a patient's residence to specialty care centers and outcomes.
• Regional referral networks of care may increase the distance for patients need to travel to receive specialty care, with unknown impact on longitudinal outcomes.
WHAT THE STUDY ADDS
• In the largest integrated healthcare system in the United States, the Veterans Affairs Healthcare System, patients travel a wide range of distances to undergo percutaneous coronary intervention through a regional referral network of cardiovascular care.
• Despite these distances, there was no association between the distance from a patient's residence to percutaneous coronary intervention centers and mortality or myocardial infarction at 1 year.
• These findings suggest that regional referral networks are safe and efficacious models for percutaneous coronary intervention care delivery.
care to minimize loss of follow-up for the assessment of longitudinal outcomes. Insurance status was determined using the insurance designated for outpatient visits within 1 year before or after the PCI and was obtained from administrative data. Primary source of medical care was assessed by the presence of at least 2 VHA primary care visits within a 2 year period surrounding PCI (1 year before and 1 year after). We determined driving distance to the PCI center from the patient's primary residence, excluding those patients that lived >800 miles away to minimize the effects of seasonal residence on distance measurements. Finally, we excluded patients missing the key stratification covariates of PCI indication and status (emergent, urgent, and elective).
Distance to PCI Center
Residential location was determined using the latitude and longitude of the address listed in the deidentified VA Master Patient Index, which was cross-referenced with the zip code listed at the time of the PCI to ensure accuracy. If the zip code listed at the time of the PCI was different than the address listed in the Master Patient Index, then the centroid latitude and longitude of the zip code at the time of PCI were used as a proxy for residential location. Drive distance was calculated between the patient residential location and the PCI site. 20 Zip code centroids were determined using the zip code package in R version 3.2.2. 21 Driving distances were calculated using ArcMap 10.2.2. Patients were grouped into quintiles of distance from PCI center.
Outcomes
The primary outcome was the rate of death or hospitalization for MI within 1 year after PCI. Rates of MI were determined using administrative codes for MI readmissions 
Covariates for Adjustment
We collected data for each patient undergoing PCI, including demographic and clinical history, US census division, median household income for residency, clinical presentation (ST-segment-elevation MI, non-ST-segment-elevation MI, unstable angina or acute coronary syndrome [ACS], stable angina, or chest pain), and urgency of PCI (elective, urgent, or emergent/salvage). Finally, rates of preprocedural and discharge cardiac medications were obtained, using prescription data from the 30 days before PCI and the 30 days after hospital discharge. US census divisions and median household income by zip code were obtained from US Census data.
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Statistical Analysis
Data were reviewed for quality and missing values. We compared patient characteristics by quintile of distance from PCI centers using χ 2 tests for binary variables and ANOVA for continuous variables. We reported unadjusted proportions of combined deaths or MI hospitalizations and individual events for each quintile. Using unadjusted logistic regression modeling, we performed both a likelihood ratio test to assess improved fit with the addition of distance as well as a test of linear trend in the log odds across distances. Using generalized linear mixed models, we calculated the relative difference in odds of death or MI for each quintile, adjusting for covariates and including random intercepts for PCI centers to account for center clustering. 23 The first quintile was used as reference for initial comparisons. Similar methods were used to model individual events of death and MI at 1 year. Secondary analyses used the same methodology, stratifying the cohorts by indication (ACS versus non-ACS) and urgency of PCI (elective versus nonelective). Sensitivity analyses were performed, stratifying by age (less than and greater than or equal to age 65) to assess for lack of capture of events not covered by Medicare insurance, and evaluating the association of the aforementioned outcomes with drive time as an alternative metric assessing patient distance, determined by ArcMap 10.2.2. Additional piecewise comparisons for outcomes were performed between all possible quintile pairs. A Bonferroni correction was made to account for multiple comparisons among all piecewise comparisons resulting in an adjusted level of significance of 0.002. When reporting CIs, 95% simultaneous CIs at a confidence level of 99.8% were presented. All statistical analyses were performed using R version 3.2.2. This study was approved by the Colorado Multiple Institutional Review Board with a waiver of informed consent.
RESULTS
Cohort
The VHA has 149 facilities in the United States. During the study period, cardiac catheterization and coronary angiography were available at 75 centers (50.3%) and PCI available at 64 centers (42.9%). A total of 50 834 PCIs were performed from 2008 to 2012. After excluding patients with private insurance (n=7870, 15.5%), nonindex PCIs (n=7778, 15.3%), those living >800 miles away from PCI centers (n=230, 0.7%), not using the VA as primary medical care (n=1380, 2.7%), and patients missing key clinical or demographic information (n=3458, 9.8%), 31 483 patients undergoing index PCI across 64 centers from 2008 to 2012 represented the analytic cohort ( Figure 1 ).
Patient Distance From PCI Center and Characteristics
Driving distance to PCI center ranged from <1 mile to 798.6 miles, with a median distance of 48.0 miles (interquartile range, 17.0-110.3). By quintile of distance from PCI center, median driving distance from patient residence to PCI center in the nearest quin-tile (Qn1) was 7.0 miles (range <1.0-13.0), 21.2 miles (range 13.0-32.8) in the second nearest quintile (Qn2), 48.0 miles (range 32.8-69.6) in the third nearest quintile (Qn3), 95.6 miles (range 69.6-129.2) in the fourth nearest quintile (Qn4), and 188.2 miles (range 129.2-798.6) in the furthest quintile (Qn5). Patients living further away from PCI centers were more likely to be of white race, have higher proportions of Medicare/Medicaid insurance coverage, have higher body mass index, and higher rates of depression, hypertension, hyperlipidemia, prior MI, and current tobacco use (Tables 1 and 2 ). Patients living further from PCI centers were less likely to present with ST-segmentelevation MI or non-ST-segment-elevation MI but more likely to present with unstable angina or stable angina symptoms. Elective PCI was more common for patients living further away from PCI centers. There were differences in medications prescribed before PCI, with increased rates of statin, antiplatelet, and β-blocker prescriptions among patients living further from PCI centers. However, differences in rates of medication prescription after hospital discharge were modest across quintiles and not likely to be of clinical significance (Table 3 ). (14) 748 (12) PCI indicates percutaneous coronary intervention; and Qn, quintile.
Unadjusted Outcomes
At 1 year, the overall rate of death or hospitalization for MI was 9.3%. The rate of death or MI hospitalization was highest among patients living in the nearest to PCI centers (Qn: 11.3%), with decreasing rates of death or hospitalization for MI at 1 year in quintiles further away from PCI centers (Qn: 9.8%, Qn: 9.4%, Qn: 8.0%, Qn: 7.8%). The overall rate of mortality at 1 year after PCI was 6.2%, with mortality highest among patients living nearest to PCI centers (Qn: 7.5%), with decreasing mortality at further distances (Qn: 6.8%, Qn: 6.0%, Qn: 5.7%, Qn: 5.1%). The overall rate of hospitalization for MI was 3.7%, with rates of MI hospitalization highest among those nearest to PCI centers (Qn: 4.3%, Qn: 3.7%, Qn: 4.0%, Qn: 3.1%, Qn: 3.2%). Relative odds of the composite and individual outcomes decreased with increasing patient distance from PCI centers (Figure 2A 
Adjusted Outcomes
After adjustment, there was no significant difference in the relative odds of death or MI hospitalization for patients with increasing driving distance from PCI center, as compared with those living closest to centers ( Figure 3A) . Pairwise comparisons between quintiles of distance demonstrated similar odds of death or MI hospitalization at 1 year across all quintiles ( Table I in the Data Supplement). There was no difference in the relative odds of death for patients with increasing distance from PCI center as compared with those living closest to centers ( Figure 3B ). Pairwise comparisons across quintiles did not demonstrate any significant difference in odds of mortality (Table II in the Data Supplement). There was no significant difference in the relative odds of MI at 1 year between patients with increased distance from PCI center as compared with those living closest to centers ( Figure 3C ). Similarly, pairwise comparisons did not demonstrate any significant difference in the odds of MI across all quintiles of distance from PCI centers (Table III in the Data Supplement). (21) 1231 (20) 1446 (23) 1548 (25) 1571 (25) <0.001
Cerebrovascular disease 1143 (18) 1077 (17) 1131 (18) 1081 (17) 1095 (17) (20) 1234 (20) 1225 (20) 1203 (19) 1194 (19) 60-90 3002 (48) 3248 (52) 3331 (53) 3344 (53) 3317 (53) >90 1669 (27) 1530 (24) 1519 (24) 1533 (24) 1612 (26 (21) 1328 (21) 1412 (22) 1397 (22) 1351 (22) 0.234
Prior CABG 1415 (23) 1567 (25) 1756 (28) 1789 (28) All reported values are n (%) unless otherwise specified. BMI indicates body mass index; CABG, coronary artery bypass grafting; COPD, chronic obstructive pulmonary disease; MI, myocardial infarction; NYHA, New York Heart Association; PCI, percutaneous coronary intervention; and Qn, quintile.
Secondary and Sensitivity Analyses
Secondary analyses stratifying variables of PCI indication (ACS versus non-ACS), and urgency of PCI (elective versus nonelective) did not find differences in the relative odds of death or MI hospitalization at 1 year across quintiles within each stratum ( Figure 4A and 4B) . Sensitivity analyses were also performed, stratifying the cohort by age (<65 years versus ≥65 years; Figure 4C ), and analyzing the cohort using estimated drive time as opposed to driving distance. There remained no difference in the relative odds of death of MI hospitalization at 1 year across quintiles.
DISCUSSION
We found that US veterans travel a wide range of distances to undergo PCI, with 25% traveling >110 miles.
We found no association between patient distance from PCI center and longitudinal outcomes of death or hospitalization for MI at 1 year. Stratification by PCI indication and urgency similarly did not find an association between distance and outcomes. These findings suggest that longitudinal outcomes of PCI are similar regardless of distance traveled from the PCI center and that a regional referral network spoke and hub model may offer an effective means to deliver PCI care without adversely impacting longitudinal patient outcomes.
Prior studies investigating the impact of patient distance from care centers have mainly focused on either access to care, 11, 24, 25 or on inpatient outcomes. [26] [27] [28] The few studies that have evaluated the impact of patient distance on longitudinal outcomes have focused mainly on oncological care. These prior studies suggested the existence of a distance bias effect, with improved sur- (26) 1451 (23) 1255 (20) 1083 (17) 922 (15) Unstable angina 1493 (24) 1515 (24) 1666 (27) 1762 (28) (24) 1555 (25) 1555 (25) 1514 (24) 1490 (24) 3 or LMCA involvement 1402 (22) 1427 (23) 1512 (24) 1380 (22) 1407 (22) Missing 881 (14) 859 (14) 873 (14) 1013 (16) 1067 (17) Preprocedure medications
Antiplatelet agent* 1275 (20) 1376 (22) 1450 (23) 1594 (25) vival among patients traveling further to receive cancer care. 8, 9, 29 Proposed explanations for this distance bias include residual confounding from differences in functional status, social determinants of health, or greater orientation to healthcare among patients willing to travel further distances for care (ie, manifesting a will to live through a clustering of behaviors). 27 This distance bias was not evident in the present analysis of death and hospitalization for MI after PCI, rather demonstrating that these longitudinal outcomes do not vary across quintiles of distance from PCI center.
Our findings may differ from prior analyses for a variety of reasons. First, it is possible that this distance bias may be disease or procedure-specific: oncology care is different from PCI in that often PCI results in a significant improvement in functional status by relieving ischemic symptoms. Therefore, by undergoing PCI, potential confounding of functional status interaction with distance may be lessened. Second, prior studies focused on complex oncological care. Such care generally requires multiple visits to the advanced care center, which can further magnify functional status disparity (ie, only the healthiest of patients will be able to travel to continue receiving chemotherapy). In the case of PCI, while the initial visit requires advanced care, follow-up has evolved to include multiple options including telephone visits, e-consults, and comanagement with local proximal primary care physicians. These differences may lessen the contribution of functional capacity disparities. Additionally, by using the VA electronic medical record, we were able to adjust for a large number of covariates that could serve as surrogates or contributors to many of the social determinants of health. These may not have been readily available for prior analyses, limiting adjustment. Finally, income restrictions for health insurance in the VHA likely define a cohort with a more homogenous socioeconomic status than that seen in prior studies of oncological clinical trials. This may limit the potential disparities in unmeasured social determinants of health seen across distances from specialty care.
Our findings have several important implications. First, we are the first to report the wide range of distances traveled by veterans to undergo PCI, demonstrating the breadth of coverage in the VA despite limited resources. Second, finding that death and hospitalization for MI in the year after PCI do not vary across distances traveled suggest that a regional referral network spoke and hub model of care may be a viable strategy to broaden care delivery for invasive cardiovascular procedures without adversely impacting patient outcomes. It is possible that such a strategy could have similar efficacy across procedural services like endoscopy or specialized surgeries. Further studies are needed to substantiate a spoke and hub model for other specialty procedures. With US healthcare turning more toward integrated healthcare networks and consolidation of services, 30 these findings may assist strategic planning for delivery of procedural care.
This study should be interpreted in the context of its design. First, as an observational analysis, causality cannot be inferred as residual confounding may be present. However, we performed robust statistical adjustment for a wide variety of covariates to minimize effects of measured confounders. Second, by relying on administrative data to determine hospitalization for MI, it is possible that we may have underestimated the primary study end point. However, by limiting the cohort to patients primarily using the VA for medical care and supplementing our data with that from Medicare, we likely captured the vast majority of billing for our study cohort. Furthermore, we performed a sensitivity analysis of patients stratifying the cohort by age ≥65 or <65 years of age (ie, below the age of Medicare eligibility), finding a similar relationship between patient distance and outcome across strata as that seen in the general cohort. It would be highly unlikely to miss MI events at similar rates across strata when supplementing the >65 years of age patients with Medicare data. Third, the study only evaluated patients that underwent PCI, to understand the implications of distance from specialty centers on outcomes. Hence, this analysis is unable to determine implications for initial patient access to PCI and specialty care. Fourth, the findings of this analysis may not be generalizable to facilities that are not part of an integrated healthcare system with regional referral networks. However, consolidated healthcare services and integrated healthcare services are becoming more commonplace in the United States, and these findings may carry significant implications for their development and planning. 30 Additionally, this analysis was not able to assess patients' perspective and attitudes, which represent a key piece in developing models of care. However, this analysis demonstrates that such a model of care is feasible and safe, without diminishing outcomes. Finally, these results may not be generalizable to patients not well represented in the VA. Further studies in other populations, specifically women or minorities, are needed to improve the strength of these conclusions.
CONCLUSIONS
In this cohort of US veterans, 50% traveled >48 miles to undergo PCI, and 25% traveled >110 miles. Despite this range of distances traveled, there was no association between patient distance to PCI center and outcomes of death or MI at 1 year. These findings suggest that the spoke and hub model of care provided within the VHA for PCI is a viable model for healthcare delivery.
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